Correlation Between Integrated Biopharma and Hormel Foods
Can any of the company-specific risk be diversified away by investing in both Integrated Biopharma and Hormel Foods at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Integrated Biopharma and Hormel Foods into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Integrated Biopharma and Hormel Foods, you can compare the effects of market volatilities on Integrated Biopharma and Hormel Foods and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Integrated Biopharma with a short position of Hormel Foods. Check out your portfolio center. Please also check ongoing floating volatility patterns of Integrated Biopharma and Hormel Foods.
Diversification Opportunities for Integrated Biopharma and Hormel Foods
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Integrated and Hormel is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Integrated Biopharma and Hormel Foods in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hormel Foods and Integrated Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Integrated Biopharma are associated (or correlated) with Hormel Foods. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hormel Foods has no effect on the direction of Integrated Biopharma i.e., Integrated Biopharma and Hormel Foods go up and down completely randomly.
Pair Corralation between Integrated Biopharma and Hormel Foods
Given the investment horizon of 90 days Integrated Biopharma is expected to generate 2.94 times more return on investment than Hormel Foods. However, Integrated Biopharma is 2.94 times more volatile than Hormel Foods. It trades about -0.01 of its potential returns per unit of risk. Hormel Foods is currently generating about -0.04 per unit of risk. If you would invest 39.00 in Integrated Biopharma on November 2, 2024 and sell it today you would lose (6.00) from holding Integrated Biopharma or give up 15.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 22.52% |
| Values | Daily Returns |
Integrated Biopharma vs. Hormel Foods
Performance |
| Timeline |
| Integrated Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Hormel Foods |
Integrated Biopharma and Hormel Foods Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Integrated Biopharma and Hormel Foods
The main advantage of trading using opposite Integrated Biopharma and Hormel Foods positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Integrated Biopharma position performs unexpectedly, Hormel Foods can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hormel Foods will offset losses from the drop in Hormel Foods' long position.| Integrated Biopharma vs. Premier Foods Plc | Integrated Biopharma vs. Torque Lifestyle Brands | Integrated Biopharma vs. Naturally Splendid Enterprises | Integrated Biopharma vs. Aryzta AG PK |
| Hormel Foods vs. Campbell Soup | Hormel Foods vs. General Mills | Hormel Foods vs. Kellanova | Hormel Foods vs. Lamb Weston Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |